The price of NeuBase Therapeutics Inc (NASDAQ: NBSE) closed at $1.00 in the last session, down -2.91% from day before closing price of $1.03. In other words, the price has decreased by -$0.0300 from its previous closing price. On the day, 508987 shares were traded. NBSE stock price reached its highest trading level at $1.0512 during the session, while it also had its lowest trading level at $0.9810.
Ratios:
We take a closer look at NBSE’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.87 and its Current Ratio is at 2.87. In the meantime, Its Debt-to-Equity ratio is 0.58 whereas as Long-Term Debt/Eq ratio is at 0.53.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on February 12, 2021, Reiterated its Buy rating but revised its target price to $18 from $15 previously.
On June 16, 2020, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $16.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 14 ’23 when Symetryx Corp sold 129,108 shares for $1.44 per share. The transaction valued at 185,916 led to the insider holds 153,337 shares of the business.
Symetryx Corp sold 3,376 shares of NBSE for $4,861 on Sep 11 ’23. The 10% Owner now owns 472,926 shares after completing the transaction at $1.44 per share. On Sep 08 ’23, another insider, Symetryx Corp, who serves as the 10% Owner of the company, sold 128,847 shares for $1.53 each. As a result, the insider received 197,136 and left with 476,302 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NBSE now has a Market Capitalization of 3.65M and an Enterprise Value of -3.58M.
Stock Price History:
Over the past 52 weeks, NBSE has reached a high of $5.40, while it has fallen to a 52-week low of $0.59. The 50-Day Moving Average of the stock is 0.7755, while the 200-Day Moving Average is calculated to be 0.9872.
Shares Statistics:
According to the various share statistics, NBSE traded on average about 204.62K shares per day over the past 3-months and 131.71k shares per day over the past 10 days. A total of 3.73M shares are outstanding, with a floating share count of 3.03M. Insiders hold about 18.88% of the company’s shares, while institutions hold 12.76% stake in the company. Shares short for NBSE as of Feb 29, 2024 were 199.81k with a Short Ratio of 0.98, compared to 12.64k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 5.36% and a Short% of Float of 5.52%.
Earnings Estimates
The company has 0 analysts who recommend its stock at the moment. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$2.2. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.
